| Name | KRAS G12C inhibitor 31 |
|---|
| Description | KRAS G12C inhibitor 31 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 1. KRAS G12C inhibitor 31 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
KRAS G12C[1] |
| References |
[1]. Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1. |
| Molecular Formula | C25H22ClFN6O3 |
|---|---|
| Molecular Weight | 508.93 |